ArticleDermatology and therapy2026

Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registry.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.